Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study

NCT05679713 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT05679713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05679713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Observational
Overall status
Unknown status
Start date
September 5, 2022
Completion date
December 1, 2024
Enrollment
1,134 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure